SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,163 | -25.4% | 6,387 | 0.0% | 0.00% | – |
| Q2 2023 | $29,700 | -0.1% | 6,387 | -0.7% | 0.00% | – |
| Q1 2023 | $29,720 | -42.8% | 6,433 | 0.0% | 0.00% | – |
| Q4 2022 | $51,979 | +205.8% | 6,433 | +106.3% | 0.00% | – |
| Q3 2022 | $17,000 | -98.8% | 3,118 | -98.9% | 0.00% | -100.0% |
| Q2 2022 | $1,447,000 | +10235.7% | 277,760 | +30289.5% | 0.00% | – |
| Q4 2021 | $14,000 | -64.1% | 914 | -55.9% | 0.00% | – |
| Q3 2021 | $39,000 | 0.0% | 2,074 | -0.7% | 0.00% | – |
| Q2 2021 | $39,000 | -99.5% | 2,089 | -99.4% | 0.00% | -100.0% |
| Q1 2021 | $7,483,000 | +161.6% | 328,774 | +149.5% | 0.02% | +150.0% |
| Q4 2020 | $2,861,000 | +9765.5% | 131,797 | +3440.1% | 0.01% | – |
| Q2 2020 | $29,000 | – | 3,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |